COVID-19 Vaccines May Pose 'Unique and Heightened Risk' of Contaminated DNA Fragment Integration into Human Body: Florida Surgeon General

Can "transform a healthy cell into a cancerous cell."

In a strongly worded letter dated December 6, 2023, Florida Surgeon General Joseph A. Ladapo raised significant concerns to the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) regarding the safety and efficacy of COVID-19 vaccines.

The letter, addressed to FDA Commissioner Robert M. Califf and CDC Director Mandy Cohen emphasized the discovery of DNA fragments in the Pfizer and Moderna COVID-19 mRNA vaccines.

Dr. Ladapo’s letter reflects a deep concern about the “presence of nucleic acid contaminants in the approved Pfizer and Moderna COVID-19 mRNA vaccines,” particularly in the context of their lipid nanoparticle delivery systems.

The letter reasons that because lipid nanoparticles are said to be an efficient vehicle for the delivery of COVID vaccines into human cells, they might “therefore be an equally efficient vehicle for delivering contaminant DNA into human cells.”

The Surgeon General expressed his apprehension about the potential risks of these DNA fragments.

He specifically referred to the Simian Virus 40 (SV40) promoter/enhancer DNA, noting that the “presence of SV40 promoter/enhancer DNA may also pose a unique and heightened risk of DNA integration into host cells.”

In his correspondence, Dr. Ladapo referenced FDA guidance from 2007 concerning DNA vaccines, highlighting the potential impacts of DNA integration on human health.

“DNA integration could theoretically impact a human’s oncogenes—the genes which can transform a healthy cell into a cancerous cell,” he quoted from the FDA document. “DNA integration may result in chromosomal instability.”

The letter posed several critical questions to the FDA and CDC, including whether drug manufacturers have evaluated the risk of human genome integration or mutagenesis from residual DNA contaminants in the vaccines:

“Have drug manufacturers evaluated the risk of human genome integration or mutagenesis of residual DNA contaminants from the mRNA COVID-19 vaccines alongside the additional risk of DNA integration from the lipid nanoparticle delivery system and SV40 promoter/enhancer? Has FDA inquired any information from the drug manufacturers to investigate such risk?”

The letter also asked: “Considering the potentially wide biodistribution of mRNA COVID-19 vaccines and DNA contaminants beyond the local injection site, have you evaluated the risk of DNA integration in reproductive cells with respect to the lipid nanoparticle delivery system?”

Given the widespread administration of these vaccines, Dr. Ladapo stressed the need for a swift response, requesting a written reply by December 13, 2023, to address both his previous letter and the concerns raised in the current one.

“The American people and the scientific community have a right to have all relevant information pertaining to the COVID-19 vaccines to properly inform individual decision-making,” he stated, emphasizing the urgency and importance of transparent communication on these matters.